82 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
21 Recruiting Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
22 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
23 Unknown  Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Condition: Healthy
Intervention: Drug: Indobufen
24 Recruiting Reversal of Dabigatran Anticoagulant Effect With Idarucizumab
Condition: Hemorrhage
Intervention: Drug: idarucizumab
25 Recruiting Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
Condition: Benign Prostatic Hyperplasia
26 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
27 Recruiting An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers
Conditions: Stroke;   Prevention and Control;   Atrial Fibrillation
Intervention: Drug: Xarelto, Pradaxa and Eliquis
28 Unknown  D-Dimer Guided Oral Anticoagulant Treatment (OAT)
Condition: Deep Venous Thrombosis
Interventions: Drug: Phenprocoumon;   Drug: Warfarin-Natrium
29 Recruiting A Study in Patients With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants
Condition: Bleeding
Intervention: Biological: Andexanet
30 Unknown  Antihemostatic Therapy and Endoscopic Biliary Sphincterotomy Induced Bleeding
Conditions: Endoscopic Biliary Sphincterotomy;   Bleeding
31 Recruiting START-Register: Survey on Anticoagulated Patients Register
Conditions: Atrial Fibrillation;   Venous Thromboembolism;   Heart Valve Diseases or Prosthesis;   Other Heart or Peripheral Vascular Diseases Leading to Chronic Anticoagulation
Interventions: Drug: Anticoagulants;   Drug: anticoagulants
32 Recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
33 Recruiting Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)
Condition: Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke
34 Recruiting Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
35 Recruiting Anticoagulant Utilization Pattern
Condition: Atrial Fibrillation
36 Recruiting Global Anticoagulant Registry in the Field
Condition: Atrial Fibrillation
37 Recruiting Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer
Conditions: Lymphoma;   Multiple Myeloma
Interventions: Drug: Tinzaparin;   Other: Blood sample
38 Recruiting Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: novel oral anticoagulant for 30 days;   Drug: novel oral anticoagulant for 24 hour
39 Recruiting Reversal of Dabigatran With Prothrombin Complex Concentrate
Condition: Drug Action Reversal
Intervention: Drug: Beriplex
40 Recruiting Atrial Fibrillation in Turkey: Epidemiologic Registry-2
Condition: Atrial Fibrillation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years